JOSEPH CUTRUFELLI: Open Payments
NPI 1740947043 · ABINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,640 in 107 payments from 38 companies in 2025. Trend: 2023 $3,158 · 2024 $4,300 · 2025 $2,640
Food & beverage: $2,273Education: $367
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $324 |
| Janssen Biotech, Inc. | 7 | $207 |
| PFIZER INC. | 8 | $193 |
| Novartis Pharmaceuticals Corporation | 8 | $137 |
| Ipsen Biopharmaceuticals, Inc | 3 | $134 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $132 |
| Aveo Pharmaceuticals, Inc. | 2 | $121 |
| Incyte Corporation | 6 | $112 |
| SEAGEN INC. | 1 | $90 |
| E.R. Squibb & Sons, L.L.C. | 4 | $83 |
Products named: CALQUENCE, FOTIVDA, ENHERTU, DARZALEX, IBRANCE, JAKAFI, NINLARO, RUBRACA.
Industry payments across PA — which companies pay providers there.
